IL17A and rheumatoid arthritis: The pathological progression of RA is driven by an imbalance between pro‐inflammatory and anti‐inflammatory cytokines, with elevated levels of IL‐6, TNF‐α, IFN‐γ, GM‐CSF, and IL‐17A indicating severe inflammation.